BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15483627)

  • 1. Regulation of nicotinic receptor expression by the ubiquitin-proteasome system.
    Christianson JC; Green WN
    EMBO J; 2004 Oct; 23(21):4156-65. PubMed ID: 15483627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ubiquitin-proteasome system regulates the stability of neuronal nicotinic acetylcholine receptors.
    Rezvani K; Teng Y; De Biasi M
    J Mol Neurosci; 2010 Jan; 40(1-2):177-84. PubMed ID: 19693707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of glucose trimming with castanospermine reduces calnexin association and promotes proteasome degradation of the alpha-subunit of the nicotinic acetylcholine receptor.
    Keller SH; Lindstrom J; Taylor P
    J Biol Chem; 1998 Jul; 273(27):17064-72. PubMed ID: 9642271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A transmembrane motif governs the surface trafficking of nicotinic acetylcholine receptors.
    Wang JM; Zhang L; Yao Y; Viroonchatapan N; Rothe E; Wang ZZ
    Nat Neurosci; 2002 Oct; 5(10):963-70. PubMed ID: 12219096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Capture of a Disabled Proteasome Identifies Erg25 as a Substrate for Endoplasmic Reticulum Associated Degradation.
    Buck TM; Zeng X; Cantrell PS; Cattley RT; Hasanbasri Z; Yates ME; Nguyen D; Yates NA; Brodsky JL
    Mol Cell Proteomics; 2020 Nov; 19(11):1896-1909. PubMed ID: 32868373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of nicotinic acetylcholine receptor assembly.
    Wanamaker CP; Christianson JC; Green WN
    Ann N Y Acad Sci; 2003 Sep; 998():66-80. PubMed ID: 14592864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural determinants of alpha4beta2 nicotinic acetylcholine receptor trafficking.
    Ren XQ; Cheng SB; Treuil MW; Mukherjee J; Rao J; Braunewell KH; Lindstrom JM; Anand R
    J Neurosci; 2005 Jul; 25(28):6676-86. PubMed ID: 16014729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of trafficking-defective long QT syndrome type II mutant channels by the ubiquitin-proteasome pathway.
    Gong Q; Keeney DR; Molinari M; Zhou Z
    J Biol Chem; 2005 May; 280(19):19419-25. PubMed ID: 15760896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of nicotinic acetylcholine receptor turnover by tyrosine phosphorylation in rat myotubes.
    Sava A; Barisone I; Di Mauro D; Fumagalli G; Sala C
    Neurosci Lett; 2001 Nov; 313(1-2):37-40. PubMed ID: 11684334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERAD: the long road to destruction.
    Meusser B; Hirsch C; Jarosch E; Sommer T
    Nat Cell Biol; 2005 Aug; 7(8):766-72. PubMed ID: 16056268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of the sodium taurocholate cotransporting polypeptide (NTCP) by the ubiquitin-proteasome system.
    Kühlkamp T; Keitel V; Helmer A; Häussinger D; Kubitz R
    Biol Chem; 2005 Oct; 386(10):1065-74. PubMed ID: 16218878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency of acetylcholine receptor subunit assembly and its regulation by cAMP.
    Ross AF; Green WN; Hartman DS; Claudio T
    J Cell Biol; 1991 May; 113(3):623-36. PubMed ID: 1849906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway.
    Schubert U; Antón LC; Bacík I; Cox JH; Bour S; Bennink JR; Orlowski M; Strebel K; Yewdell JW
    J Virol; 1998 Mar; 72(3):2280-8. PubMed ID: 9499087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two endoplasmic reticulum-associated degradation (ERAD) systems for the novel variant of the mutant dysferlin: ubiquitin/proteasome ERAD(I) and autophagy/lysosome ERAD(II).
    Fujita E; Kouroku Y; Isoai A; Kumagai H; Misutani A; Matsuda C; Hayashi YK; Momoi T
    Hum Mol Genet; 2007 Mar; 16(6):618-29. PubMed ID: 17331981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of altered ubiquitin-proteasome system and ER stress in the muscle atrophy of diabetic rats.
    Reddy SS; Shruthi K; Prabhakar YK; Sailaja G; Reddy GB
    Arch Biochem Biophys; 2018 Feb; 639():16-25. PubMed ID: 29277369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoplasmic Reticulum-associated Degradation of Pca1p, a Polytopic Protein, via Interaction with the Proteasome at the Membrane.
    Smith N; Adle DJ; Zhao M; Qin X; Kim H; Lee J
    J Biol Chem; 2016 Jul; 291(29):15082-92. PubMed ID: 27226596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingolipids are necessary for nicotinic acetylcholine receptor export in the early secretory pathway.
    Baier CJ; Barrantes FJ
    J Neurochem; 2007 May; 101(4):1072-84. PubMed ID: 17437537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One step at a time: endoplasmic reticulum-associated degradation.
    Vembar SS; Brodsky JL
    Nat Rev Mol Cell Biol; 2008 Dec; 9(12):944-57. PubMed ID: 19002207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The recognition and retrotranslocation of misfolded proteins from the endoplasmic reticulum.
    Nakatsukasa K; Brodsky JL
    Traffic; 2008 Jun; 9(6):861-70. PubMed ID: 18315532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasome inhibitors induce nucleolar aggregation of proteasome target proteins and polyadenylated RNA by altering ubiquitin availability.
    Latonen L; Moore HM; Bai B; Jäämaa S; Laiho M
    Oncogene; 2011 Feb; 30(7):790-805. PubMed ID: 20956947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.